Related by context. All words. (Click for frequent words.) 71 RLS symptoms 69 GERD symptoms 69 PMS symptoms 67 reflux symptoms 66 OAB symptoms 66 overactive bladder symptoms 64 urinary symptoms 64 menopausal symptom 63 BPH symptoms 63 somatic symptoms 62 HbA1c levels 62 digestive discomfort 62 IBS sufferers 62 depressive symptoms 62 atopic eczema 61 hypoglycemic episodes 61 hay fever symptoms 61 solifenacin 61 symptom severity 61 COPD exacerbations 61 gout flares 61 ADHD symptoms 61 opioid analgesia 60 laxation 60 severe exacerbations 60 EXJADE 60 tapentadol ER 60 nasal obstruction 60 vasomotor symptoms 60 bloating abdominal pain 60 salivary flow 60 diabetic gastroparesis 60 virological response 60 antidepressant therapy 60 abdominal bloating 60 clinically meaningful improvement 60 hyperglycaemia 60 corticosteroid therapy 60 nighttime heartburn 60 salmeterol fluticasone 59 tolvaptan 59 asthma exacerbations 59 premenstrual syndrome PMS 59 spontaneous bowel movements 59 HPA axis suppression 59 PASI scores 59 EDSS scores 59 hemoglobin A1c HbA1c 59 tegaserod 59 knee osteoarthritis OA 59 adrenal function 59 blood Phe levels 59 prodromal symptoms 59 dose titration 59 functional dyspepsia 59 subclinical hypothyroidism 59 antioxidant supplementation 59 probiotic supplementation 59 antihypertensive therapy 59 irritable bowel syndrome IBS 58 platelet inhibition 58 #mg/day [002] 58 salivary cortisol 58 nocturnal hypoglycemia 58 glycemia 58 A1c levels 58 sustained virologic response 58 intermittent hypoxia 58 abdominal pain abdominal discomfort 58 pramipexole 58 premenstrual symptoms 58 nocturnal awakenings 58 migraineurs 58 menstrual migraine 58 metabolic acidosis 58 hypomagnesemia 58 hyperalgesia 58 menopausal symptoms 58 serum uric acid 58 apneic episodes 58 perimenopausal symptoms 58 KAPIDEX 58 allergy symptoms 58 #mg dose [001] 58 CIMZIA ™ 58 INVEGA ® 58 Irritable Bowel Syndrome 58 hypoglycemia 58 GERD 58 AVODART 58 dyspnoea 57 Candida overgrowth 57 elevated ALT 57 acute bronchospasm 57 dyspnea 57 adalimumab 57 oxycodone CR 57 corticosteroid dose 57 delayed CINV 57 plasma glucose 57 neurodevelopmental outcome 57 T2DM 57 mesalamine granules 57 xerostomia 57 hypoperfusion 57 decompensation 57 APTIVUS r 57 nasal symptoms 57 H. pylori eradication 57 sUA 57 baseline HbA1c 57 bothersome symptom 57 pyridostigmine 57 gastrointestinal symptoms 57 nocturnal hypoglycaemia 57 headache sufferers 57 aripiprazole 57 NAbs 57 constipation 57 hyperglycemia 57 B# deficiency 57 symptom flare ups 57 febrile seizure 57 ACTEMRA TM 57 Irritable Bowel Syndrome IBS 57 parkinsonian symptoms 57 dysphagia 57 neuroleptics 57 malabsorption 57 glycated hemoglobin levels 57 L. reuteri 57 exacerbations 57 dysmenorrhoea 57 MADRS score 57 virologic response 56 bacterial overgrowth 56 EDARBI 56 neuropsychiatric symptoms 56 Major Depressive Disorder 56 gastro oesophageal reflux 56 citalopram 56 GERD sufferers 56 virological failure 56 postsurgical pain 56 hypoglycemic events 56 serum urate levels 56 hepatic function 56 alexithymia 56 insulin detemir 56 exploratory endpoints 56 uncontrolled asthma 56 Crohn Disease Activity 56 ZOMIG Nasal Spray 56 lipid parameters 56 postprandial glucose 56 incontinence episodes 56 urate levels 56 antihypertensive medications 56 divalproex sodium 56 HbA 1C 56 depressive symptom 56 airway constriction 56 ARICEPT 56 BoNTA 56 nocturia 56 TNF antagonist 56 menstrual bleeding 56 hypochondriasis 56 mucosal healing 56 hot flushes 56 asthmatic symptoms 56 pregabalin 56 serum cortisol 56 TEAEs 56 alteplase 56 hypokalemia 56 serum concentrations 56 idiopathic Parkinson disease 56 clomipramine 56 hypersomnia 56 platelet reactivity 56 glycosylated hemoglobin HbA1c 56 HbA 1c levels 56 hypercalcemia 56 folic acid intake 56 symptoms 56 intermittent claudication 56 postprandial insulin 56 bronchodilation 56 transaminase levels 56 β blockers 56 nighttime awakenings 56 CIMZIA TM 55 hemoglobin A1c levels 55 chronic urticaria 55 Adalimumab 55 hemodynamic instability 55 MCyR 55 laboratory abnormalities 55 systemic corticosteroid 55 CONCERTA ® 55 hematological toxicity 55 akathisia 55 posttransplant 55 adjunctive placebo 55 hot flashes 55 intensive statin therapy 55 fructose intolerant 55 Hematologic toxicity 55 reflux disease 55 pelvic pain 55 HAM D# 55 atopic disease 55 androgen suppression 55 postoperative pain 55 EGFRIs 55 AGILECT R 55 tolterodine ER 55 nasal allergy symptoms 55 abdominal distension 55 microalbuminuria 55 ropivacaine 55 bezafibrate 55 certolizumab 55 posttreatment 55 L lysine 55 PSADT 55 alkalosis 55 fasting plasma glucose 55 SRBD 55 hypocalcemia 55 recurrent venous thromboembolism 55 nasal symptom 55 HBeAg seroconversion 55 extrapyramidal symptoms 55 NNT = 55 levodopa therapy 55 pernicious anemia 55 bladder contractions 55 subsyndromal 55 oral corticosteroids 55 DAPT 55 virologic responses 55 rhinoconjunctivitis 55 dysmenorrhea 55 syncopal episode 55 antiplatelet medication 55 GI motility 55 ropinirole 55 mg Proellex 55 dyspareunia 55 acute gout flares 55 CDI recurrence 55 MoxDuo TM IR 55 teriflunomide 55 tardive dyskinesia TD 55 post operative ileus 55 simethicone 55 delayed gastric emptying 55 cytogenetic response 55 selenium supplementation 55 migraine sufferers 55 CPAP adherence 55 TLUS 55 calcium supplementation 55 postoperative nausea 55 upper gastrointestinal bleeding 55 sedating antihistamine 55 urinary tract symptoms 55 nasal allergies 55 Apidra ® 55 infarct size 55 rhTSH 55 HeFH 55 alanine aminotransferase ALT 55 generalized anxiety disorder GAD 55 melatonin supplements 55 rotigotine 55 serum cholesterol 55 depressive symptomatology 55 canakinumab 55 montelukast 55 tiotropium 55 serum testosterone 55 HbA 1c 55 HRQL 55 peginterferon 55 postoperative ileus 55 enuresis 55 BYSTOLIC 55 serum phosphate levels 55 octreotide LAR 55 rectal bleeding 55 MMSE scores 55 mg dose 55 parasitemia 55 diastolic dysfunction 55 ramelteon 55 Psoriasis Area 55 CANCIDAS 55 cortisol secretion 55 esomeprazole 55 bacterial prostatitis 55 urinary retention 55 Generalized Anxiety Disorder 55 lamotrigine 55 pressor response 55 placebo 55 interferon therapy 55 Acetaminophen Tylenol 55 nonvertebral fractures 55 atherogenic dyslipidemia 54 transient insomnia 54 Antidepressant medications 54 moderate renal impairment 54 mcg BID 54 hyperreflexia 54 menstrual pain 54 recurrent miscarriage 54 NATRECOR ® 54 complete cytogenetic 54 prolactin levels 54 emotional lability 54 indigestion heartburn 54 acid secretion 54 Restless Legs Syndrome 54 HRQOL 54 CMV infection 54 flow mediated dilation 54 urinary oxalate 54 CINV 54 gastric acidity 54 daytime alertness 54 pruritis 54 IBS C 54 thromboprophylaxis 54 cardiac autonomic 54 antibiotic rifaximin 54 postoperative AF 54 glomerular filtration 54 severe hypoglycemia 54 nasal allergy 54 Antacids 54 analgesic medications 54 NPH insulin 54 budesonide formoterol 54 invasive aspergillosis 54 colorectal liver metastases 54 PANSS scores 54 hypertensives 54 Index CDAI 54 endothelial function 54 Scale EDSS score 54 chronic rhinosinusitis 54 EFFEXOR XR 54 adrenal suppression 54 tranylcypromine 54 endometrial hyperplasia 54 triiodothyronine 54 CR nPR 54 stone formers 54 dietary nitrate 54 4mg/kg 54 ibandronate 54 hyperammonemia 54 oxcarbazepine 54 abdominal discomfort bloating 54 INVEGA R 54 clinically meaningful improvements 54 heartburn sufferers 54 hypoxemia 54 psychosocial functioning 54 ATACAND 54 COREG 54 Pramipexole 54 ginkgo biloba extract 54 transaminase elevations 54 timepoints 54 PYY 54 neuroleptic 54 A1C levels 54 treatment emergent AEs 54 asthma exacerbation 54 depressive relapse 54 serum sodium levels 54 icatibant 54 neurologic dysfunction 54 placebo p = 54 serum sodium 54 frequent awakenings 54 procalcitonin 54 postprandial hyperglycemia 54 HIV HCV coinfected 54 adiponectin levels 54 FOLFOX4 54 autonomic dysfunction 54 serum urate 54 amenorrhea 54 folate intake 54 testosterone supplementation 54 SGRQ 54 tissue oxygenation 54 moderate aerobic exercise 54 HSCT 54 doripenem 54 plasma glucose levels 54 extubation 54 DPNP 54 anticipatory anxiety 54 hypovolemia 54 variceal bleeding 54 Exacerbations 54 pharmacokinetic PK profile 54 chronic prostatitis 54 postdose 54 decompensated heart failure 54 clinically meaningful reductions 54 attain statistical significance 54 acarbose 54 inhaled nitric oxide 54 #mg/day [001] 54 severe menopausal symptoms 54 Traficet EN 54 triacylglycerol concentrations 54 ALT elevations 54 GERD symptom 54 carbohydrate absorption 54 T1DM 54 diarrhea flatulence 54 epigastric pain 54 QTc interval 54 evaluable subjects 54 knee osteoarthritis 54 vasodilatation 54 prucalopride 54 abrupt discontinuation 54 airway narrowing 54 recurrent genital herpes 54 COPAXONE R 54 eszopiclone 54 SAMe 54 hypotensive 54 postprandial glycemia 54 depressive episodes 54 hypertensive patients 54 dietary supplementation 54 symptomatology 54 fluid overload 54 hyperphenylalaninemia HPA due 54 EDSS score 54 tocilizumab 53 nausea constipation 53 GnRH agonists 53 fluticasone salmeterol 53 morphometric vertebral fractures 53 alvimopan 53 renal toxicity 53 intravenous bisphosphonates 53 gemifloxacin 53 vasovagal syncope 53 fluoxetine 53 secondary endpoint 53 prodrome 53 H. pylori infection 53 Symptom severity 53 serum IGF 53 HRQoL 53 AMITIZA 53 HDRS 53 antidepressant efficacy 53 QIDS SR 53 VAPRISOL 53 Restless Legs Syndrome RLS 53 urinary incontinence UI 53 Lactobacillus KW 53 atrophic gastritis 53 NIHSS score 53 hyperhydrosis 53 post operatively 53 heavy menstrual bleeding 53 fructose diet 53 constipation nausea 53 CONCERTA 53 antibiotic prophylaxis 53 thromboembolic 53 steroid dexamethasone 53 primidone 53 metabolic parameters 53 methotrexate therapy 53 acne lesions 53 primary aldosteronism 53 tryptophan depletion 53 radioiodine therapy 53 intravenous morphine 53 dopaminergic therapy 53 eosinophilic asthma 53 SE5 OH 53 lactose intolerance 53 inotropic 53 NIH CPSI 53 XZK 53 MBCT 53 febrile seizures 53 UPDRS motor 53 OSAHS 53 SCIg 53 myocardial reperfusion 53 CLBP 53 antiarrhythmic drugs 53 SSRI SNRI 53 glulisine 53 rimonabant #mg 53 neostigmine 53 oral prednisolone 53 tapentadol IR 53 daytime drowsiness 53 oral rivaroxaban 53 fasting blood glucose 53 apnea hypopnea index 53 pentoxifylline 53 myopathy rhabdomyolysis 53 urinary leakage 53 systolic hypertension 53 plus methotrexate 53 Tasimelteon 53 airway hyper responsiveness 53 detemir 53 carotid stenosis 53 glucose homeostasis 53 non menstrual pelvic 53 Placebos 53 potassium sparing diuretics 53 magnesium supplementation 53 dietary interventions 53 nonadherence 53 zolmitriptan 53 hypoglycaemia 53 CLA supplementation 53 acid regurgitation 53 CIPN 53 antidepressant monotherapy 53 androgen excess 53 Pycnogenol ® 53 patients evaluable 53 adrenal insufficiency 53 interpersonal psychotherapy 53 plasma concentrations 53 BENICAR HCT 53 magnesium intake 53 hayfever symptoms 53 QTc prolongation 53 serum triglyceride levels 53 LUTS 53 paroxysmal AF 53 Mitral Regurgitation 53 elevated creatinine 53 desvenlafaxine succinate 53 cytogenetic responses 53 reperfusion therapy 53 homocysteine concentrations 53 methotrexate monotherapy 53 recurrent abdominal pain 53 fatty acid supplementation 53 liver histology 53 blood glucose concentrations 53 aminotransferase levels 53 N acetylcysteine 53 eczema 53 dosing interval 53 frequent heartburn 53 dysmotility 53 achieved statistical significance 53 depressive episode 53 contrast induced nephropathy 53 ziconotide 53 serum phosphate 53 antipsychotic efficacy 53 topical NSAIDs 53 acne breakouts 53 orthostatic 53 iNO 53 overt hypothyroidism 53 trospium 53 perfusion defects 53 oral naltrexone 53 polyp recurrence 53 intracerebral haemorrhage 53 systolic BP 53 selegiline 53 neutropenic patients 53 ALT flares 53 coadministration 53 hypovitaminosis D 53 FOLPI regimen 53 hours postdose 53 serum PTH 53 albuminuria 53 chronic neuropathic pain 53 timepoint 53 mucosal inflammation 53 OADs 53 teriparatide 53 leukotriene receptor antagonist 53 glargine 53 sinus congestion 53 perimenopausal women 53 PONV 53 bifidobacteria 53 postoperatively 53 ventricular enlargement 53 quetiapine Seroquel 53 donepezil 53 aldosterone antagonists 53 acidosis 53 plasma homocysteine levels 53 PLMS 53 salicylates 53 baclofen 53 hyperkalemia 53 CAPHOSOL 53 anticholinergic drugs 53 neurodevelopmental outcomes 53 secondary efficacy endpoints 53 RSV infections 53 microvascular complications 53 UTIs 53 dyslipidaemia 53 tolerability 53 SGPT 53 chronic constipation 53 hypophosphatemia 53 LANTUS R 53 thrombotic complications 53 CPAP therapy 53 nonresponders 53 sedating medications 53 euthymic 53 TMP SMX 53 ACEIs 53 transaminases 53 antiarrhythmic drug 53 decrements 53 intra articular injection 53 viral suppression 53 IELT 53 gastric emptying 53 mixed hyperlipidemia 53 Hypotension 53 breastfed infants 53 aromatase inhibitor therapy 53 QTc intervals 53 Parkinsonian symptoms 53 dosing frequency 53 infantile colic 53 fibromyalgia syndrome 53 hydrolyzed formula 53 tumor shrinkage 53 lopinavir r arm 53 reflux 53 tipranavir 53 PMDD 53 vasospasm 53 artery stenosis 53 bowel motility 53 ruboxistaurin 53 acetylcysteine 53 Welchol 53 somatic complaints 53 unexplained syncope 52 RISPERDAL ® 52 ADCS CGIC 52 lipid lowering therapy 52 comorbid conditions 52 gluten sensitivity 52 oral FTY# 52 placebo controlled studies 52 AA Amyloidosis 52 proliferative diabetic retinopathy 52 nonalcoholic steatohepatitis NASH 52 serum leptin 52 chocolate cravings 52 Thal Dex 52 plasma creatinine 52 8mg/kg 52 hyperacidity 52 chemoradiation 52 HBeAg positive patients 52 periodontal infection 52 acetabular dysplasia 52 severe hypoglycemic 52 neurologic progression 52 NovoLog ® Mix 52 postoperative complication 52 bronchial thermoplasty 52 thyrotoxicosis 52 refractory gout 52 bosentan 52 RLS sufferers 52 ximelagatran 52 inflammatory lesions 52 symptomatic hypotension 52 tirofiban 52 inhaled corticosteroid therapy 52 HbA1C 52 sulfasalazine 52 Natural S equol 52 Thrombocytopenia 52 clinically meaningful 52 insomnia sufferers 52 Calcium intake 52 neurologic symptoms 52 thyrotropin 52 vitamin supplementation 52 systemic corticosteroids 52 antiepileptic drugs AEDs 52 oral corticosteroid 52 psychiatric comorbidity 52 hyperhomocysteinemia 52 vasodilation 52 AGILECT ® 52 poststroke 52 nephrotoxicity 52 airway hyperresponsiveness 52 serum calcium levels 52 cardioprotection 52 nasal congestion 52 YMRS 52 reflux disease GERD 52 NYHA functional class 52 Generalized anxiety disorder 52 fasting glucose levels 52 arterial stiffness 52 radicular pain 52 seasonal allergic rhinitis 52 musculoskeletal pain 52 Perforomist Inhalation Solution 52 radiographic progression 52 serum vitamin D 52 bronchial hyperresponsiveness 52 relapsing MS 52 hepatic fibrosis 52 alpha lipoic acid 52 ventilatory 52 anemia hemoglobin 52 Natalizumab 52 euthymic patients 52 intestinal microflora 52 blood glucose levels 52 advanced adenoma 52 acne flare ups 52 improves glycemic 52 paliperidone palmitate 52 iodine intake 52 GnRH agonist 52 leptin deficient mice 52 titrated glipizide 52 intracranial hemorrhage ICH 52 QoL 52 untreated psychosis 52 torsade de pointes 52 Nocturia 52 arthritic pain 52 oral prednisone 52 mmol l 52 DHA supplementation 52 epidural steroid injections 52 orthostatic hypotension 52 CP CPPS 52 systemic hypotension 52 sustained virological response 52 Anxiety disorders 52 dextromethorphan DM 52 antiemetics 52 intestinal motility 52 COPD exacerbation 52 psychotic symptoms 52 anal incontinence 52 gastroesophageal reflux 52 simulated acupuncture 52 poststroke depression 52 ARCOXIA 52 irregular menstrual cycles 52 treat NNT 52 FOLPI 52 Decitabine 52 hematologic parameters 52 Dysmenorrhea 52 arterial thromboembolic events 52 albumin excretion rate 52 active ankylosing spondylitis 52 quetiapine 52 acamprosate 52 CCyR 52 bolus dose 52 PRADAXA 52 PREZISTA r arm 52 LYSTEDA 52 fructose intolerance 52 chronic insomnia 52 glucocorticoid therapy 52 neurocognitive deficits 52 prazosin 52 emesis 52 oxygen desaturation 52 macrovascular 52 Cortisol levels 52 food intolerances 52 buprenorphine naloxone 52 FFNS 52 symptomology 52 PTSD symptoms 52 PREZISTA r 52 glycemic 52 lipid levels 52 Cortisone injections 52 hematuria 52 oral antihistamines 52 haematologic 52 Postoperative 52 azoospermia 52 Chronic Migraine 52 MIRAPEX 52 salmeterol HFA MDI 52 hydroxychloroquine 52 satiety 52 pruritus 52 MULTAQ 52 hsCRP levels 52 spontaneous preterm delivery 52 lacosamide 52 Health Assessment Questionnaire 52 androgen ablation 52 endotoxemia 52 candida infection 52 microvascular dysfunction 52 olanzapine 52 fasting plasma glucose FPG 52 QT intervals 52 NYHA class 52 gassiness 52 pCR 52 metronidazole gel 52 biphasic insulin aspart 52 NATRECOR R 52 plasma folate 52 iPTH 52 atopic dermatitis 52 basal insulin 52 HAQ DI 52 treprostinil 52 oral antidiabetic medication 52 insulin degludec 52 cinacalcet 52 visilizumab 52 aminotransferases 52 RLAI 52 resynchronization therapy 52 acute psychosis 52 diabetic neuropathic pain 52 polycystic ovary syndrome PCOS 52 colorectal adenoma 52 corrected QT interval 52 hyperprolactinemia 52 PGTC seizures 52 imatinib therapy 52 AVANDIA 52 p = .# [002] 52 celiac patients 52 adenotonsillectomy 52 EBV infection 52 lispro 52 hyperarousal 52 anticoagulation therapy 52 etanercept 52 TNF inhibitor 52 VaD 52 SAPHRIS 52 achalasia 52 peptide YY 52 intrathecal baclofen 52 amenorrhoea 52 subthreshold depression 52 invasive candidiasis 52 major depressive disorder 52 Hypoglycaemia 52 elevated cortisol 52 L dopa 52 serum potassium 52 CaPre ™ 52 peg interferon 52 Spinal manipulation 52 Concord grape juice 52 diarrhea nausea fatigue 52 Depressive symptoms 52 depressive disorders 52 HAART regimens 52 FSAD 52 generalized anxiety 52 nasal congestion sore throat 52 interferon ribavirin 52 tiotropium bromide 52 CAM therapies 52 neurocognitive functioning 52 atopic 52 INVEGA 52 myelosuppression 52 dyspepsia 52 #mg dose [003] 52 blood Phe 52 dosage regimens 52 magnesium deficiency 52 serum estradiol 52 anticholinergic effects 52 nocebo 52 hematological parameters 52 mepolizumab 52 BENICAR 52 nausea photophobia 52 serologically active patients 52 sertraline Zoloft 52 dysuria 52 antithrombotics 52 inhaled fluticasone 52 events AEs 52 riociguat 52 serum folate concentrations 52 antiandrogens 52 plus ribavirin 52 nicardipine 52 highly emetogenic 52 chronic heartburn 52 systolic function 52 celiac disease 52 psychoactive medication 52 cardiac toxicity 52 disordered breathing 52 autoantibody levels 52 Scale EDSS 52 menstrual migraines 52 haemodynamic 52 serum clusterin levels 52 symptomatic VTE 52 MS relapses 52 valacyclovir 52 serotonin synthesis 52 DETROL LA 52 Relora 52 myocardial fibrosis 52 postprocedure 52 gastrointestinal GI 52 PCOD 52 perioperative complications 52 allergic rhinitis hay fever 52 recurrent UTI 51 Hypocalcemia 51 plasma uric acid 51 beta blocker therapy 51 Endothelial function 51 claudication 51 posaconazole 51 thyroxine 51 zafirlukast 51 Hepatotoxicity 51 hypertonic saline 51 adrenocorticotropic hormone 51 LEXIVA r 51 gastrointestinal toxicity 51 achieved ACR# 51 opioid induced constipation 51 bulimia nervosa 51 severe hypoglycaemia 51 neurologic complications 51 complete remissions 51 leucopenia 51 virologic failure 51 subscale scores 51 receiving XGEVA 51 detrusor overactivity 51 angina chest 51 nonvertebral fracture 51 diabetic polyneuropathy 51 ACZ# 51 aripiprazole Abilify 51 efalizumab 51 chronic pancreatitis 51 Pycnogenol 51 rotavirus infection 51 leukopenia 51 INVEGA ® SUSTENNA TM 51 GH deficiency 51 serum creatinine levels 51 autoimmune reactions 51 Major Depressive Disorder MDD 51 akinetic mutism 51 acromegalic patients 51 glycemic control 51 #.#/#.# mmHg [001] 51 SILENOR TM 51 gouty arthritis